Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
21
|
pubmed:dateCreated |
1988-8-19
|
pubmed:abstractText |
5-Lipoxygenase has been expressed in a mammalian osteosarcoma cell line transfected with the cloned cDNA for human leukocyte 5-lipoxygenase. Two clonal cell lines derived from the transfected cells expressed the enzymatic activity. When incubated with arachidonic acid (100 microM), the major 5-lipoxygenase products of 10,000 X g supernatants from these cells were 5-hydroxyeicosatetraenoic acid (5-HETE), and the nonenzymatic hydrolysis products of leukotriene (LT)A4. The ratio of 5-HETE to LT (between 6:1 and 9:1) was similar to that observed in leukocyte supernatants. Furthermore, incubation of 10,000 X g supernatants from the transfected cells with 5-hydroperoxyeicosatetraenoic acid (5-HPETE) (75 microM) resulted in the synthesis of LTA4 hydrolysis products. Control osteosarcoma cell supernatants produced no 5-HETE or LT from arachidonic acid or 5-HPETE. Maximal activity of the expressed enzyme required Ca2+, ATP, and two cellular stimulatory factors prepared from human leukocytes. Immunoblot analysis of supernatants from the osteosarcoma cell clones revealed an immunoreactive 80,000-dalton band that was indistinguishable from the band observed in leukocyte supernatants. Therefore, the expressed enzyme was functional and exhibited characteristics that were identical to those of human leukocyte 5-lipoxygenase. When intact transfected osteosarcoma cells were challenged with ionophore A 23187, no 5-lipoxygenase products were formed. If arachidonic acid was added along with the ionophore, the cells synthesized 5-HETE and the nonenzymatic hydrolysis products of LTA4. These results verify that the cDNA used to transfect the osteosarcoma cells encodes for 5-lipoxygenase. Furthermore, these studies offer independent evidence that this single protein possesses both 5-lipoxygenase and LTA4 synthase activity, as has been reported previously from enzyme purification data.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
25
|
pubmed:volume |
263
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
10135-40
|
pubmed:dateRevised |
2006-5-1
|
pubmed:meshHeading |
pubmed-meshheading:3164719-Arachidonate 5-Lipoxygenase,
pubmed-meshheading:3164719-Arachidonate Lipoxygenases,
pubmed-meshheading:3164719-Cell Line,
pubmed-meshheading:3164719-Cloning, Molecular,
pubmed-meshheading:3164719-Genes,
pubmed-meshheading:3164719-Genetic Vectors,
pubmed-meshheading:3164719-Humans,
pubmed-meshheading:3164719-Kinetics,
pubmed-meshheading:3164719-Leukocytes,
pubmed-meshheading:3164719-Nucleotide Mapping,
pubmed-meshheading:3164719-Osteosarcoma,
pubmed-meshheading:3164719-Plasmids,
pubmed-meshheading:3164719-Transfection
|
pubmed:year |
1988
|
pubmed:articleTitle |
Characterization of cloned human leukocyte 5-lipoxygenase expressed in mammalian cells.
|
pubmed:affiliation |
Department of Pharmacology, Merck Frosst Canada Incorporated, Dorval, Quebec, Canada.
|
pubmed:publicationType |
Journal Article
|